Objective and Aims for Project 3The internalization and recycling of cell surface receptors, glucose transporters, and other plasmamembrane proteins is regulated by phosphoinositide metabolism as well as GTPases of the Rab and Arffamilies. Defects in these regulatory mechanisms have been implicated in a variety of disease statesincluding cancer and type II diabetes. The long term objective of Project 3 is to characterize poorlyunderstood mechanisms that integrate phosphoinositide signaling and Rab/Arf GTPase activation with thedynamic molecular assemblies that mediate/regulate trafficking events at the plasma membrane and withinthe endosomal system. To achieve this objective, we will combine crystallographic, biochemical,biophysical, and mutational studies on purified complexes with complementary structure-function analyses incollaboration with Projects 1, 2, 4, and the imaging core. Building on the observations of the previousfunding period and extensive new preliminary data, we will:
(Aim 1) examine the structural determinants ofautoregulation and phosphoinositide dependent membrane targeting in the Grp1 family of Arf GTPaseexchange factors;
(Aim 2) investigate the mechanism of autoregulation, membrane targeting, and Rabactivation by the Rabex-5/Rabaptin-5 complex and Rin1;
and (Aim 3) explore the structural bases forregulation of endocytic recycling by phosphoinositide dependent and independent complexes of EHDproteins with Rabenosyn-5, EHBP1, and FIP2.Relevance to Public HealthBoth type II diabetes and cancer involve defects in the mechanisms by which cell surface receptors forinsulin and growth factors communicate with the molecular machinery that controls cell metabolism andgrowth. By studying these mechanisms comprehensively at the structural, molecular, and cellular levelsthrough collaborative projects the combine the expertise of structural, molecular, and cell biologists we hopeto identify novel mechanism-based strategies that can be exploited for therapeutic intervention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
2P01DK060564-06A1
Application #
7299617
Study Section
Special Emphasis Panel (ZDK1-GRB-W (J1))
Project Start
2007-06-10
Project End
2012-04-30
Budget Start
2007-06-10
Budget End
2008-04-30
Support Year
6
Fiscal Year
2007
Total Cost
$578,667
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Ly, Socheata; Navaroli, Deanna M; Didiot, Marie-Cécile et al. (2017) Visualization of self-delivering hydrophobically modified siRNA cellular internalization. Nucleic Acids Res 45:15-25
Rohatgi, R A; Janusis, J; Leonard, D et al. (2015) Beclin 1 regulates growth factor receptor signaling in breast cancer. Oncogene 34:5352-62
Stockler, Sylvia; Corvera, Silvia; Lambright, David et al. (2014) Single point mutation in Rabenosyn-5 in a female with intractable seizures and evidence of defective endocytotic trafficking. Orphanet J Rare Dis 9:141
Malaby, Andrew W; van den Berg, Bert; Lambright, David G (2013) Structural basis for membrane recruitment and allosteric activation of cytohesin family Arf GTPase exchange factors. Proc Natl Acad Sci U S A 110:14213-8
Davey, Jonathan R; Humphrey, Sean J; Junutula, Jagath R et al. (2012) TBC1D13 is a RAB35 specific GAP that plays an important role in GLUT4 trafficking in adipocytes. Traffic 13:1429-41
Li, Jian; Malaby, Andrew W; Famulok, Michael et al. (2012) Grp1 plays a key role in linking insulin signaling to glut4 recycling. Dev Cell 22:1286-98
Young, James L; Mora, Alfonso; Cerny, Anna et al. (2012) CD14 deficiency impacts glucose homeostasis in mice through altered adrenal tone. PLoS One 7:e29688
Navaroli, Deanna M; Bellve, Karl D; Standley, Clive et al. (2012) Rabenosyn-5 defines the fate of the transferrin receptor following clathrin-mediated endocytosis. Proc Natl Acad Sci U S A 109:E471-80
Tan, Shi-Xiong; Ng, Yvonne; Burchfield, James G et al. (2012) The Rab GTPase-activating protein TBC1D4/AS160 contains an atypical phosphotyrosine-binding domain that interacts with plasma membrane phospholipids to facilitate GLUT4 trafficking in adipocytes. Mol Cell Biol 32:4946-59
Xie, Xiangyang; Gong, Zhenwei; Mansuy-Aubert, Virginie et al. (2011) C2 domain-containing phosphoprotein CDP138 regulates GLUT4 insertion into the plasma membrane. Cell Metab 14:378-89

Showing the most recent 10 out of 33 publications